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P Rheeder, J T van Wyk, J W E Hokken, H M Hueting 
Objective. To compare the detection of diabetic neuropathy 
using monofilament, cotton wool, pinprick, vibration sense 
and symptom evaluation. 
Setting. The diabetes clinic of a community hospital. 
Methods. Two examiners evaluated 89 women with diabetes 
mellitus (OM) using a 10 g monofilament, cotton wool, 
pinprick and a 128 Hz tuning fork after completion of a 
University of Texas subjective peripheral neuropathy verbal 
questionnaire. 
Results. Vibration sense was abnormal in either foot in 8% of 
subjects. Neuropathy as defined by monofilament, cotton 
wool and pinprick was present in 26%, 3% and 6% of 
patients respectively. The respective kappa values (K) for the 
comparison between monofilament neuropathy and cotton 
wool neuropathy, pinprick neuropathy and symptom-
defined neuropathy were 0.18, 0.21 and 0.06. The K-value 
comparing monofilament and tuning fork-defined 
neuropathy was 0.24. There was fair agreement between 10 
versus 3 sites (K = 0.60). 
Conclusion. More abnormalities were detected using the 
monofilament compared with cotton wool or pinprick. 
There was poor concordance between symptoms and 
clinically detected neuropathy. The ideal number of sites 
that need to be evaluated is still contentious. 
S Afr Med J 2002: 92: 715-719. 
Diabetic foot complications are the commonest cause of non-
traumatic lower extremity amputations in the industrialised 
world. The risk of lower extremity amputation is 15 - 46 times 
higher in patients with diabetes mellitus (OM) than in persons 
who do not have DMY Furthermore, diabetic foot 
complications are the most frequent reason for hospitalisation 
in patients with OM, accounting for up to 25% of all diabetic 
admissions in the USA and Great Britain.' A non-healing foot 
ulcer precedes approximately 85% of all amputations. Diabetic 
Clinical Epidemiology Unit, University of Pretoria 
P Rheeder, MB ChB, FCP(SA), MMed, MSc 
J T van Wyk, MB ChB 
J W E Hokken, medical student 
H M Hueting, medical student 
foot ulcers and lower extremity amputations are serious and 
expensive complications that occur in as many as 15% of 
people with OM during their lifetime.' The incidence of 
diabetes-related lower extremity amputation in South Africa is 
unknown. Relatively simple inexpensive interventions may 
decrease the amputation rate by up to 85%.5 The neuropathic 
component in the aetiological pathway (less than 15% of ulcers 
are purely ischaemic)'·7 is so important that the emphasis in the 
foot examination is on neurological testing. 
Various studies have identified the monofilament as a valid 
and sensitive instrument to predict foot ulceration and/ or 
amputation by detecting neuropathy.'·11 However, the method 
employed and the number of sites tested varies in different 
studies and guidelines. The International Working Group on 
the Diabetic Foot12 advises that 3 sites be tested, in comparison 
with the 10 sites used by Armstrong and Lavery' (Fig. 1). 
Holewski et al.13 used the dorsal surface of the foot between the 
first and second toes and the base of the third and fifth 
metatarsals. Olmos et al. 1' tested three sites, the Hansen's 
Disease Center15 recommends testing 10 sites and Kumar et al.16 
tested only one site. The monofilament is not widely available 
in all settings in South Africa. Many clinics use cotton wool, 
pinprick and vibration sense to detect neuropathy. The aim of 
our study was to determine the prevalence of and agreement 
between monofilament, cotton wool, pinprick, vibration sense 
and symptom-defined neuropathy in a group of South African 
OM subjects. 
Fig. 1. Possible monofilament testing sites (10 sites (dots) of 
Armstrong and Lavery' and 3 sites (call outs) of the International 
Working Group on the Diabetic Foot12). 
METHODS 
This cross-sectional study was done at Mamelodi Hospital, a 
community hospital in the Mamelodi suburb of Pretoria, South 
Africa. For most patients with OM this hospital serves as their 
source of primary care. Female patients in the waiting room of 
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the Mamelodi Hospital diabetes outpatient clinic, aged 
between 30 and 70 years and with type 2 DM, were invited to 
participate. Female subjects were chosen because they 
represent approximately three-quarters of the diabetes clinic 
and in our experience they are also more likely to keep 
research-related appointment visits than the men. A total of 134 
women were invited and 112 (83.6%) wished to participate. Of 
these, 93 patients (69.4%) subsequently came to the clinic for 
evaluation. Patients were compensated for their transportation 
costs. Approval was obtained from the Ethics and Protocol 
Committee of the Pretoria Academic Hospital. Informed 
consent was obtained from every participant. 
Two medical students evaluated the feet during their 
research elective. Before the project they completed a 3-week 
period of orientation and training. During this period the 
questionnaire and examination were standardised. All patients 
visited the clinic twice. Approximately six patients a day were 
examined, on three days of the week. 
The evaluation included a standardised questionnaire, basic 
clinical measurements and neurovascular evaluation of the 
patients' feet. Neurological symptoms were evaluated using 
the University of Texas subjective peripheral neuropathy verbal 
questionnaire.' This consists of four questions: (i) do your feet 
ever feel numb?; (ii) do your feet ever tingle, as if electricity 
were travelling into your foot?; (iil) do your feet ever feel as if 
insects were crawling on them?; and (iv) do your feet ever 
burn? A positive answer to any of the four questions was 
regarded as a positive response for neuropathy. An interpreter 
was used when a patient was not able to understand or answer 
the questions in English. 
Weight was determined to the nearest 0.1 kg standing 
barefoot in light clothing on a calibrated electronic scale 
(Tanita, Tokyo). Height was determined to the nearest 0.1 em 
using a measuring stick attached to the wall. Body mass index 
(BMI) was calculated as mass/height in m'. Waist-hip ratio was 
determined by measuring the waist at the smallest diameter 
below the xiphisternum and the umbilicus (at the end of a mild 
expiration), and the hips at the level of maximal protrusion of 
the gluteus maximus muscles posteriorly and the symphysis 
pubis anteriorly. Two measurements were taken and if there 
was more than 2 em difference a third was taken. The mean of 
the two measurements or the closest two in the case of three 
measurements were used to calculate the waist-hip ratio. 
Measurements were done to the nearest 0.1 em. Blood pressure 
was measured in the sitting position after at least 5 minutes' 
rest, with the right arm resting on a table, using a mercury 
baumanometer. Two measurements were taken with at least 
1 minute between measurements. If there was a difference of 
more than 5 mmHg between readings a third reading was 
taken and the mean of the two closest measurements was used 
to determine the mean blood pressure. Mid-arm circumference 
was measured, and a large cuff (18 em rubber bladder) was 
used for an arm circumference 33 em or greater. The dorsalis 
pedis and tibialis posterior arteries were palpated in both feet. 
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Neurological evaluation 
Vibration sense was tested using a 128 Hz tuning fork. The 
forehead was used as a reference of normal vibratory sense. 
This was evaluated by asking the subjects what they felt, a 
response indicating vibration was acceptable. The first 
metatarsal head was tested initially; if vibration sense was not 
present the test proceeded to the medial malleolus, and if still 
not present the tuberositas tibia was tested. Vibration sense 
was graded as present or absent. 
Proprioception was tested by placing the examiner's fingers 
on the lateral aspects of the big toe and moving it plantarly and 
dorsally. The patients were asked to close their eyes and tell the 
examiner the position of the big toe (up or down). Sensation 
was evaluated using a 5.07/10 g monofilament (Sensory 
Testing Systems, Dallas) cotton wool and pinprick (using a 
wooden toothprick) at 10 specified sites. The forehead was 
used as a reference for normal sensory perception. Before 
evaluation, the testing was demonstrated on patients' hands so 
that they were familiar with the procedure. Subjects were 
instructed to close their eyes and to indicate when and in 
which foot they felt the monofilament. Where callus was 
present at a particular site, the closest area without callus was 
used. The order in which the sites were tested was random. 
The cotton wool and pinprick assessments were performed in 
the same way. A second examiner undertook the cotton wool 
and pinprick evaluations (blinded to the monofilament results. 
The testing instrument was applied once to each site, and 
absence of sensation at four or more sites was regarded as 
indicating neuropathy.'·' 
Data analysis 
Descriptive statistics included means and standard deviations 
for parametric data and medians with 25th and 75th quartiles 
for non-parametric data. Concordance was evaluated using the 
Kappa statistic. Kappa (K) is a measure of agreement between 
two observers that takes into account the agreement expected 
by chance, in the formula: Agreement between observers 
(%)-agreement expected by chance(%) 100- agreement 
expected by chance (%). 
It has a maximum of 1.00 when agreement is perfect, a value 
of zero indicates agreement no better than chance, and negative 
values show less than chance agreement.17 Continuous data 
between groups were compared using Student's t-tests or 
Mann-Whitney U-tests depending on the distribution of the 
data. 
RESULTS 
One patient was excluded from the analysis as she failed to 
understand the instructions regarding the foot examination and 
3 subjects had their data recorded at a later date. Both 
examiners examined 21 patients and the K-value for 
monofilament-defined neuropathy was 0.71 (good strength of 
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agreement).17 Table I shows the basic characteristics of the 
study population. The mean age was 58.1 years, and the mean 
BMI 31.8 kg/m', with a mean body fat percentage of 42.1 %. 
The results of the foot examination are given in Table II. In 11% 
of the subjects both tibialis posterior and dorsalis pedis arteries 
were not palpable in either foot. Vibration sense tested on the 
first metatarsal head was abnormal in 8% of all subjects. These 
were all at the level of the first metatarsal head; tested on the 
medial malleolus and tuberositas tibiae no abnormalities were 
found. Proprioception was normal in all the subjects. 
Regarding neuropathy, more abnormalities were detected with 
Table I. Characteristics of the study population 
Median 
Mean (25th and 75th 
N (SD) 12ercentile) 
Age (yrs) 89 58.09 (8.31) 
Education (yrs) 89 6.00 (3.00, 8.00) 
BMI (m/kg') 88 31.75 (5.15) 
Waist-hip ratio 89 0.86 (0.07) 
Systolic BP (mmHg) 89 149.38 (25.47) 
Diastolic BP (mmHg) 89 88.75 (10.95) 
S-HbA1c (%) 81 9.81 (2.27) 
F-S LDL (mmol/l) 82 3.19 (1.20) 
F-S HDL (mmol/l) 82 1.37 (0.39) 
F-S TG (mmol/l) 82 1.19 (0.79, 1.87) 
F-S cholesterol 82 5.32 (1.54) 
(mmol/1) 
F-S Lp (a) (mg/ dl) 81 45.10 (25.20, 89.70) 
S-creatinine 82 76.78 (36.41) 
(mmol/l) 
Albumin/ creatinine 80 1.15 (0.68, 4.18) 
ratio (mg/mmol) 
N N(%) 
Ethnic group 89 
Sotho/Pedi 40 (44.9) 
Zulu 18 (20.2) 
Other 31 (34.8) 
Postmenopausal 89 68 (76.4) 
Duration of DM 89 
~ 5 years 42 (47.2) 
> 5 years 47 (52.8) 
DM treatment 88 
Diet 2 (2.3) 
Oral agents 66 (75.3) 
Insulin 20 (22.7) 
Hypertensive 89 70 (78.9) 
Alcohol users* 89 5 (5.6) 
* Answering 'yes' to 'Do you use alcohol?'. 
SD ; standard deviation; BMI ; body mass index; BP ; blood pressure; 
S..HbA1c ;haemoglobin Ale; F-S..LD-L; fasting serum low-density lipoprotein; 
F-5 HDL; fasting serum high-density lipoprotein; F-S TG ; fasting serum 
triglyceride; F-S cholesterol ; fasting serum cholesterol; F-S Lp(a) ; fasting 
serum lipoprotein (a); S-creatinine ; serum creatinine. 
Table II. Abnormalities found on foot examination 
Abnormality N Prorortion (%) 
Dorsalis pedis 89 10 (11.2) 
and tibialis posterior absent 
Vibration sense 89 7 (7.9) 
abnormal* 
Neuropathy' 
Monofilament 89 23 (25.8) 
Pinprick 89 3 (3.3) 
Cotton wool 89 5 (5.6) 
Neuropathy 89 67 (75.3) 
according to 
questionnaire! 
*At first metatarsal head of either foot. 
t Neuropathy defined as sensation absent at four or more sites either left 
and/ or right. 
t University of Texas Neuropathy Questionnaire. 
the monofilament (26%) compared with the pinprick (3%) and 
the cotton wool (6%). Most of the patients (75%) reported 'yes' 
to at least one of the neuropathy symptom questions. 
Table III shows the comparison for neuropathy defili.ed 
according to monofilament, pinprick cotton wool and the 
neurological questionnaire. The K-values for the pinprick, 
cotton wool, the neurological questionnaire and vibration sense 
are 0.18, 0.21, 0.06 and 0.24 respectively. The same table shows 
the concordance between testing for neuropathy with a 
monofilament according to Armstrong et al.' and Lavery et al.10 
using 10 sites, and the method recommended by the 
International Working Group on the Diabetic Foot" using only 
3 sites, under the hallux, metatarsal 1 and metatarsal 5. The 
K-value is 0.60, which is considered moderate." 
We did not find any differences between the neuropathy 
group (monofilament-defined) and the non-neuropathy group 
as far as age, duration of diabetes, lipid values or haemoglobin 
A1, (HbA1cl were concerned (P > 0.05). The only other long-
term complication measured in this study was nephropathy 
(urinary albumin creatinine ratio). The median ratio was 1.95 in 
the neuropathy group (N = 20) and 1.15 in the non-neuropathy 
group (N = 60, P = 0.69). 
DISCUSSION 
In this sample of 89 women from a diabetic clinic with a study 
population of approximately 800 (men and women), 11% of 
patients had both foot pulses absent on palpation. Vibration lifJ 
sense was absent in at least one foot in 8% and monofilament-
defined neuropathy was present in 26%. Cotton wool and the 
pinprick examination detected neuropathy far less frequently 
and the neuropathy symptom questionnaire showed poor 
concordance with monofilament-defined neuropathy. The 
Texas questionnaire appears to be overly sensitive in this 
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Table III. Concordance between different measures of neuropathy 
Agreement(%) Expected (%) Kappa value Standard error 
Pinprick* 
Monofilament* No Yes 
No 66 0 
Yes 20 3 
Cotton wool 
Monofilament* No Yes 
No 65 1 
Yes 19 4 
Questionnaire' 
Monofilament* No Yes 
No 18 48 
Yes 4 19 
Vibration 
sense1 
Monofilament* No Yes 
No 64 18 
Yes 2 5 
Monofilament 
2 2/3 sites 
absent 
Monofilament 
2 4/10 sites absent No Yes 
No 64 2 
Yes 10 13 
* Four or more sites absent either left or right. 
tAt least one neuropathy question affirmative. 






population, with 75% of subjects answering 'yes' to at least one 
of the questions. 
Even though the subject selection was not completely 
random it is felt that the subjects were fairly representative of 
women seen at the clinic. Another possible limitation is that 
medical students performed the examinations. However, after 
a 3-week training period they performed these examinations 
up to standard. Both examiners (JWEH, HMH) evaluated the 
first 21 patients. They were blinded regarding each other's 
evaluation. The findings of the pinprick and cotton wool exam 
may have influenced the monofilament exam. Of the 21 
patients, however, only 4 had cotton wool-defined neuropathy 
and 2 had pinprick-defined neuropathy. 
There is currently an emphasis on prevention of lower 
extremity amputation in subjects with DM. A number of 
studies have recently been done with the aim of optimising the 
peripheral neurological screening exam. 
Many of these studies did not use the monofilament as an 
explicit part of the screening evaluation. In those that do, there 
was no standard way of using the monofilament. There has 
been an attempt by the International Working Group on the 
Diabetic Foot12 to standardise the monofilament screening 
(subsequently endorsed by the International Diabetes 
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72.5 0.18 006 
71.4 0.21 0.07 
37.8 0.06 0.06 
70.4 0.24 0.08 
66.0 0.60 0.10 
Federation). For details on the practical screening of the 
diabetic foot see http://www.diabetic-foot-consensus.com and 
htt://ndep.nih.gov/materials/pubs/feet/feet.htm as well as Fig. 
2. Monofilaments can be ordered from the USA 
(http://www.bphc.hrsa.gov/leap/) or the Netherlands 
(verkoop@wpbpododepot.nl). 
Pham et al.n evaluated predictors of ulceration prospectively 
in a group of subjects with diabetes. They identified the 
neuropathy disability score (a clinical examination) combined 
with a 10 g monofilament test as having the best sensitivity, 
and foot pressure measurement combined with the neuropathy 
disability score as having the best specificity for prediction of 
ulceration. Meijer et a/.1' devised a hierarchical scoring system 
based on the neuropathy disability score. Their resultant 8-item 
Diabetic Neuropathy Examination (DNE) at a cut-off level of 
3 - 4 had a sensitivity and specificity of 0.96 and 0.57 for 
abnormal monofilament scores respectively. Franse et alY have 
shown that although there is a significant association between 
symptoms of pain, sensory alteration and 'numbness of the 
feet' in particular, and a clinical neurological examination, the 
prediction of polyneuropathy from neuropathic symptoms was 
unsatisfactory. 
In general, simple clinical measures such as ankle reflexes, 
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Fig. 2. Correct way of applying the 1.5-second buckling force of the 
monofilament. 
vibration sense (as assessed by a 128 Hz tuning fork) and 
monofilament testing are recommended as basic screening 
tools for amputation prevention. Neuropathy detected by 
monofilament has been shown to predict ulceration and also 
has less inter-person and test-retest variability. Inter- and intra-
rater agreement K-values are 0.72 and 0.83.20 Testing of the 
plantar surface of the toes and metatarsal heads provides most 
of the discriminatory ability; the dorsum and the heel provide 
little additional information according to some.13 The proposed 
cut-offs for defining an insensate foot range from 1 to 3 out of 6 
sites, providing a sensitivity of 0.84 - 1.00 and specificity of 
0.77- 1.00 to predict a current or future ulcer.' 
The International Working Group on the Diabetic Foot12 has 
proposed guidelines based on expert opinion. They advise 
monofilament testing at 3 sites, using three tests at each site 
with one sham. Two out of three abnormal tests at a particular 
site will then be regarded as abnormal. Others such as 
Armstrong et a/.8•9 and Lavery et a/.10 have validated their 
system using 10 sites and using a single 'yes' response as an 
indicator of sensation present. 
Our study using only the single 'yes' response for sensation 
if present tested at 3 sites instead of 10 would have missed 10 
of 23 subjects with neuropathy (as defined by 4 or more 
abnormal sites). In our patient population we find the use of 3 
tests per site including one sham cumbersome and difficult for 
the patients to understand (this may reflect difficulties in 
communication because of language barriers). 
McGill and co-workers" investigated the effect of testing at 
different sites and found that at least one abnormal test at the 
plantar aspect of the first metatarsal or the plantar aspect of the 
fifth metatarsal had the best combined sensitivity (80%) and 
specificity (86%). In practice they then advise testing these two 
sites only. 
The use of the monofilament, even though simple in and of 
itself, can be complicated by a number of factors. Not all10 
monofilaments are the same with regard to buckling force and 
a single monofilament should not be used on more than 10 
patients on a given day, after which adequate time should be 
given for filament recovery." 
Our study is small and represents approximately 15% of the 
diabetic women seen at this clinic. Neuropathy was also not 
validated by quantitative testing. The monofilament has, 
however, been validated in other studies as a screening tool for 
neuropathy and the high-risk foot. In our study the proportion 
of subjects deemed at risk according to screening guidelines 
varies depending on the examination technique used. 
Monofilament testing identifies a larger proportion of such 
patients than does cotton wool or pinprick examination, but 
the optimal sites to be tested are still unclear. 
This study was part of the larger Mamelodi Diabetes Foot Study, 
which was funded by the Hendrik Verwoerd Research Trust. 
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